AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
TIMING OF COMBINED CHEMORADIOTHERAPY IN THE CONSERVATIVE TREATMENT OFLOCALLY ADVANCED BREAST-CANCER (LABC)
Authors: PIERGA JY CAMPANA F LAGUERRE B PALANGIE T FOURQUET A ASSELAIN B DIERAS V BEUZEBOC P DORVAL T SCHOLL S POUILLART P
Citation: Jy. Pierga et al., TIMING OF COMBINED CHEMORADIOTHERAPY IN THE CONSERVATIVE TREATMENT OFLOCALLY ADVANCED BREAST-CANCER (LABC), European journal of cancer, 34, 1998, pp. 42-42
INITIAL VERSUS DELAYED RADIOTHERAPY COMBINED WITH CONTINUOUS 5-FLUOROURACILE (F), CYCLOPHOSPHAMIDE (C) AND DOXORUBICINE (A) IN INFLAMMATORYBREAST-CANCER (IBC)
Authors: PALANGIE T ASSELAIN B CAMPANA F BEUZEBOC P DIERAS V DORVAL T JOUVE M PIERGA JY SCHOLL S POUILLART P
Citation: T. Palangie et al., INITIAL VERSUS DELAYED RADIOTHERAPY COMBINED WITH CONTINUOUS 5-FLUOROURACILE (F), CYCLOPHOSPHAMIDE (C) AND DOXORUBICINE (A) IN INFLAMMATORYBREAST-CANCER (IBC), European journal of cancer, 34, 1998, pp. 64-64
PREDICTIVE FACTORS OF RESPONSE TO FIRST LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER (MBC)
Authors: ROBAIN M PIERGA JY LAURENCE V JOUVE M DIERAS V BEUZEBOC P PALANGIE T DORVAL T SCHOLL S EXTRA JM ASSELAIN B POUILLART P
Citation: M. Robain et al., PREDICTIVE FACTORS OF RESPONSE TO FIRST LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER (MBC), Annals of oncology, 9, 1998, pp. 71-71
TREATMENT OF LIVER METASTASES FROM UVEAL MELANOMA BY COMBINED SURGERY-CHEMOTHERAPY
Authors: SALMON RJ LEVY C PLANCHER C DORVAL T DESJARDINS L LEYVRAZ S POUILLART P SCHLIENGER P SERVOIS V ASSELAIN B
Citation: Rj. Salmon et al., TREATMENT OF LIVER METASTASES FROM UVEAL MELANOMA BY COMBINED SURGERY-CHEMOTHERAPY, European journal of surgical oncology, 24(2), 1998, pp. 127-130
RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS
Authors: KEILHOLZ U CONRADT C LEGHA SS KHAYAT D SCHEIBENBOGEN C THATCHER N GOEY SH GORE M DORVAL T HANCOCK B PUNT CJA DUMMER R AVRIL MF BROCKER EB BENHAMMOUDA A EGGERMONT AMM PRITSCH M
Citation: U. Keilholz et al., RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 2921-2929
MALIGNANT-MELANOMA - CURRENT CONTROVERSIE S AND FUTURE PERSPECTIVES
Authors: DORVAL T
Citation: T. Dorval, MALIGNANT-MELANOMA - CURRENT CONTROVERSIE S AND FUTURE PERSPECTIVES, Bulletin du cancer, 85(2), 1998, pp. 187-190
CYTOKINES AND GROWTH-FACTORS
Authors: DORVAL T
Citation: T. Dorval, CYTOKINES AND GROWTH-FACTORS, Bulletin du cancer, 85(1), 1998, pp. 89-90
RANDOMIZED TRIAL COMPARING PROTRACTED INFUSION OF 5-FLUOROURACIL WITHWEEKLY DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH A MONTHLY BOLUS FAC REGIMEN IN METASTATIC BREAST-CARCINOMA (SPM90)
Authors: PIERGA JY JOUVE M ASSELAIN B LIVARTOWSKI A BEUZEBOC P DIERAS V SCHOLL S DORVAL T PALANGIE T GARCIAGIRALT E POUILLART P
Citation: Jy. Pierga et al., RANDOMIZED TRIAL COMPARING PROTRACTED INFUSION OF 5-FLUOROURACIL WITHWEEKLY DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH A MONTHLY BOLUS FAC REGIMEN IN METASTATIC BREAST-CARCINOMA (SPM90), British Journal of Cancer, 77(9), 1998, pp. 1474-1479
CHARACTERIZATION OF SOLUBLE GP130 RELEASED BY MELANOMA CELL-LINES - APOLYVALENT ANTAGONIST OF CYTOKINES FROM THE INTERLEUKIN-6 FAMILY
Authors: MONTEROJULIAN FA BRAILLY H SAUTES C JOYEUX I DORVAL T MOSSERI V YASUKAWA K WIJDENES J ADLER A GORIN I FRIDMAN WH TARTOUR E
Citation: Fa. Monterojulian et al., CHARACTERIZATION OF SOLUBLE GP130 RELEASED BY MELANOMA CELL-LINES - APOLYVALENT ANTAGONIST OF CYTOKINES FROM THE INTERLEUKIN-6 FAMILY, Clinical cancer research, 3(8), 1997, pp. 1443-1451
CYTOKINE-BASED IMMUNOTHERAPY OF SOLID TUMORS (REVIEW)
Authors: FRIDMAN WH PAGES F LEE RS MATHIOT C DORVAL T THIOUNN N POUILLART P DEBRE B TARTOUR E
Citation: Wh. Fridman et al., CYTOKINE-BASED IMMUNOTHERAPY OF SOLID TUMORS (REVIEW), Oncology Reports, 4, 1997, pp. 235-240
RESPONSE TO CHEMOTHERAPY IS THE FIRST PROGNOSTIC FACTOR IN METASTATICBREAST-CANCER
Authors: PIERGA JY JOUVE M ASSELAIN B DIERAS V BEUZEBOC P PALANGIE T DORVAL T GARCIAGIRALT E SCHOLL S POUILLART P
Citation: Jy. Pierga et al., RESPONSE TO CHEMOTHERAPY IS THE FIRST PROGNOSTIC FACTOR IN METASTATICBREAST-CANCER, European journal of cancer, 33, 1997, pp. 653-653
TREATMENT OF OCULAR MELANOMA METASTATIC TO THE LIVER BY HEPATIC ARTERIAL CHEMOTHERAPY
Authors: LEYVRAZ S SPATARO V BAUER J PAMPALLONA S SALMON R DORVAL T MEULI R GILLET M LEJEUNE F ZOGRAFOS L
Citation: S. Leyvraz et al., TREATMENT OF OCULAR MELANOMA METASTATIC TO THE LIVER BY HEPATIC ARTERIAL CHEMOTHERAPY, Journal of clinical oncology, 15(7), 1997, pp. 2589-2595
PHASE-II TRIAL OF DOXORUBICIN, 5-FLUOROURACIL, ETOPOSIDE, AND CISPLATIN IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA
Authors: PIERGA JY DIERAS V BEUZEBOC P DORVAL T PALANGIE T JOUVE M SCHOLL SM GARCIAGIRALT E POUILLART P
Citation: Jy. Pierga et al., PHASE-II TRIAL OF DOXORUBICIN, 5-FLUOROURACIL, ETOPOSIDE, AND CISPLATIN IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA, Gynecologic oncology, 66(2), 1997, pp. 246-249
BRCA1 SEQUENCE VARIATIONS IN 160 INDIVIDUALS REFERRED TO A BREAST OVARIAN FAMILY CANCER CLINIC/
Authors: STOPPALYONNET D LAURENTPUIG P ESSIOUX L PAGES S ITHIER G LIGOT L FOURQUET A SALMON RJ CLOUGH KB POUILLART P ALAPETITE C ALEPEE B KLIJANIENKO J ASSELAIN B BEUZEBOC P BOURGEOIS D BOURGEOIS H BOURSTYN E BRUNIN F CAMPANA F CHAUVEINC F COSSET JM DECREMOUX P DELAROCHEFORDIERE A DELATTRE C DEMARGERIE V DESTGAUDENS AB DIERAS V DORVAL T DUBRAY B DURAND JC FALCOU MC FITOUSSI F GARCIAGIRALT E GIRAUD P GAUTIER C GUGLIELMINA JN HAMELIN JP HOFFMAN H JAULERRY C JOUVE M LABETA C LEGALL M MAGDELENAT H MEUNIER M MOSSERI V NGUYEN TT NATALI JC NEUENSCHWANDER S NOS C OLIVIER L PALANGIE T PIERGA JY PONTVERT D ROGE P SASTREGAREAU X SCHLIENGER P SCHOLL S SELINGER R THIBAULT F THIS P TROPHILME D VALIDIRE P VIELH P VILCOQ JR VINCENTSALOMON A VOILLEMOT N ZAFRANI B BONAITIPELLIE C THOMAS G
Citation: D. Stoppalyonnet et al., BRCA1 SEQUENCE VARIATIONS IN 160 INDIVIDUALS REFERRED TO A BREAST OVARIAN FAMILY CANCER CLINIC/, American journal of human genetics, 60(5), 1997, pp. 1021-1030
IMMUNOTHERAPY IN THE TREATMENT OF CANCER
Authors: TARTOUR E DORVAL T LEE RS FRIDMAN WH
Citation: E. Tartour et al., IMMUNOTHERAPY IN THE TREATMENT OF CANCER, La Presse medicale, 25(35), 1996, pp. 1717-1722
PROTRACTED CONTINUOUS-INFUSION OF 5-FLUOROURACIL IN COMBINATION WITH DOXORUBICIN, VINCRISTINE, AND ORAL CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER
Authors: RAYMOND E PALANGIE T JOUVE M ASSELAIN B DIERAS V BEUZEBOC P DORVAL T GARCIAGIRALT E LIVARTOWSKI A SCHOLL S POUILLART P
Citation: E. Raymond et al., PROTRACTED CONTINUOUS-INFUSION OF 5-FLUOROURACIL IN COMBINATION WITH DOXORUBICIN, VINCRISTINE, AND ORAL CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER, Cancer investigation, 14(2), 1996, pp. 91-97
PREDICTORS OF CLINICAL-RESPONSE TO INTERLEUKIN-2-BASED IMMUNOTHERAPY IN MELANOMA PATIENTS - A FRENCH MULTIINSTITUTIONAL STUDY
Authors: TARTOUR E BLAY JY DORVAL T ESCUDIER B MOSSERI V DOUILLARD JY DENEUX L GORIN I NEGRIER S MATHIOT C POUILLART P FRIDMAN WH
Citation: E. Tartour et al., PREDICTORS OF CLINICAL-RESPONSE TO INTERLEUKIN-2-BASED IMMUNOTHERAPY IN MELANOMA PATIENTS - A FRENCH MULTIINSTITUTIONAL STUDY, Journal of clinical oncology, 14(5), 1996, pp. 1697-1703
PHASE-II TRIAL OF DECAPEPTYL (D-TRP-6), A POTENT LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG IN UNTREATED ADVANCED BREAST-CANCER
Authors: GARCIAGIRALT E BEUZEBOC P DIERAS V DORVAL T JOUVE M LIVARTOWSKI A PALANGIE T SCHOLL S POUILLART P
Citation: E. Garciagiralt et al., PHASE-II TRIAL OF DECAPEPTYL (D-TRP-6), A POTENT LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG IN UNTREATED ADVANCED BREAST-CANCER, American journal of clinical oncology, 19(5), 1996, pp. 455-458
TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA WITH COMBINATION OF ETOPOSIDE, CISPLATIN, AND 5-FLUOROURACIL - A PHASE-II STUDY
Authors: PIERGA JY DIERAS V PARAISO D DORVAL T PALANGIE T BEUZEBOC P JOUVE M SCHOLL SM GARCIAGIRALT E POUILLART P
Citation: Jy. Pierga et al., TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA WITH COMBINATION OF ETOPOSIDE, CISPLATIN, AND 5-FLUOROURACIL - A PHASE-II STUDY, Gynecologic oncology, 60(1), 1996, pp. 59-63
HEPATIC METASTASIS (HM) FROM UVEAL MELANOMA (UM)
Authors: SALMON RJ DESJARDINS L DORVAL T POUILLART P SCHOLL S LEYVRAZ S PLANCHET C ASSELAIN B
Citation: Rj. Salmon et al., HEPATIC METASTASIS (HM) FROM UVEAL MELANOMA (UM), Vision research, 36, 1996, pp. 3141-3141
THE TREATMENT OF CHOROIDAL MELANOMA BY I-PLAQUES
Authors: DESJARDINS L LEVY C SCHLIENGER P ROSENWALD JC ASSELAIN B DORVAL T SALMON RJ VALIDIRE P
Citation: L. Desjardins et al., THE TREATMENT OF CHOROIDAL MELANOMA BY I-PLAQUES, Vision research, 36, 1996, pp. 3145-3145
MENINGEAL CARCINOMATOSIS IN PATIENTS WITH BREAST-CARCINOMA - CLINICAL-FEATURES, PROGNOSTIC FACTORS, AND RESULTS OF A HIGH-DOSE INTRATHECAL METHOTREXATE REGIMEN
Authors: FIZAZI K ASSELAIN B VINCENTSALOMON A JOUVE M DIERAS V PALANGIE T BEUZEBOC P DORVAL T POUILLART P
Citation: K. Fizazi et al., MENINGEAL CARCINOMATOSIS IN PATIENTS WITH BREAST-CARCINOMA - CLINICAL-FEATURES, PROGNOSTIC FACTORS, AND RESULTS OF A HIGH-DOSE INTRATHECAL METHOTREXATE REGIMEN, Cancer, 77(7), 1996, pp. 1315-1323
INFILTRATING LOBULAR CARCINOMA OF THE BREAST - CLINICOPATHOLOGICAL ANALYSIS OF 975 CASES WITH REFERENCE TO DATA ON CONSERVATIVE THERAPY ANDMETASTATIC PATTERNS
Authors: SASTREGARAU X JOUVE M ASSELAIN B VINCENTSALOMON A BEUZEBOC P DORVAL T DURAND JC FOURQUET A POUILLART P
Citation: X. Sastregarau et al., INFILTRATING LOBULAR CARCINOMA OF THE BREAST - CLINICOPATHOLOGICAL ANALYSIS OF 975 CASES WITH REFERENCE TO DATA ON CONSERVATIVE THERAPY ANDMETASTATIC PATTERNS, Cancer, 77(1), 1996, pp. 113-120
IMMUNE REACTIVITY AND ANERGIA IN BREAST-C ANCER
Authors: SCHOLL S DORVAL T POUILLART P
Citation: S. Scholl et al., IMMUNE REACTIVITY AND ANERGIA IN BREAST-C ANCER, Bulletin du cancer, 83(7), 1996, pp. 535-541
BREAST-TUMOR RESPONSE TO PRIMARY CHEMOTHERAPY PREDICTS LOCAL AND DISTANT CONTROL AS WELL AS SURVIVAL
Authors: SCHOLL SM PIERGA JY ASSELAIN B BEUZEBOC P DORVAL T GARCIAGIRALT E JOUVE M PALANGIE T REMVIKOS Y DURAND JC FOURQUET A POUILLART P
Citation: Sm. Scholl et al., BREAST-TUMOR RESPONSE TO PRIMARY CHEMOTHERAPY PREDICTS LOCAL AND DISTANT CONTROL AS WELL AS SURVIVAL, European journal of cancer, 31A(12), 1995, pp. 1969-1975
Risultati: 1-25 | 26-40